Also, we still do not know how many shares will be needed for Farmacias.
" Consideration to be paid for the acquisition of Farmacias will be in shares of Aurora and based on a valuation of the proforma distribution revenue projections of Farmacias." ?
The newest deal has nothing to do with shares or dilution until 2024 which they have options ...Only their acquisition which is tiny compared to others.
The private placement investor(s) had access to information through the due diligence process that folks like us do not. One thing for sure is the investor(s) aren’t ponying up $250 million without believing they get paid back with interest or see upside on a future conversion. There’s more to this particular event that needs to be told. No one here knows.
Market Data 
Markets 
AI
